Edit

PROCEPT BIOROBOTICS

https://www.procept-biorobotics.com/

Last activity: 31.10.2024

Probably Closed

Categories: AutonomousCareProductRobotics

PROCEPT BioRobotics is a privately held surgical robotics company enabling better patient care by developing transformative solutions in urology. With an initial focus on benign prostatic hyperplasia (BPH), PROCEPT has developed Aquablation® therapy, a novel and disruptive treatment for enlarged prostate. The company’s first product, the AquaBeam® System, is the world’s first surgical robot providing autonomous tissue removal for the safe and effective treatment of BPH, independent of prostate anatomy or surgeon experience.
procept-biorobotics.com

Mentions

Location: United States, California, Redwood City

Total raised: $245M

Investors 1

Date	Name	Website
-	Perceptive...	perceptive...

Funding Rounds 3

Date	Series	Amount	Investors
30.06.2021	-	$85M	-
21.02.2018	-	$118M	-
07.07.2015	-	$42M	-

Mentions in press and media 18

Date	Title	Description
31.10.2024	Dr. Ali Afshar Opens New Urology Practice in Beverly Hills, Providing Advanced Men's and Prostate Health Care	Dr. Ali Afshar Dr. Ali Afshar, a board-certified urologist, has opened a new practice, Dr. Ali Afshar, M.D. Men's and Prostate Health, in Beverly Hills, CA, offering advanced and compassionate urological care for men's and prostate health. ...
16.08.2024	The Rise of Innovation: Neptune Medical and Findem Forge New Paths in Healthcare and Talent Acquisition	In the ever-evolving landscape of technology and healthcare, two companies are making waves. Neptune Medical and Findem are not just participants; they are leaders, carving out niches that promise to reshape their respective industries. Nep...
15.08.2024	Neptune Medical Announces $97M Series D Financing and Spinout of Jupiter Endovascular	BURLINGAME, Calif.–(BUSINESS WIRE)–August 15, 2024– Neptune Medical, a leader in medical device innovation, today announced the successful spinout of its subsidiary, Jupiter Endovascular, following the completion of a $97 million Series D f...
10.04.2023	PROCEPT BioRobotics Corp. Announces United Healthcare Coverage of Aquablation Therapy for Men with Enlarged Prostates	PROCEPT BioRobotics Corporation, a surgical robotics company focused on advancing patient care by developing transformative solutions in urology, announced that United Healthcare published an update to its Prostate Surgeries and Interventio...
22.11.2022	Российский MedTech: старые проблемы и новые возможности	Российский рынок медицинских технологий на фоне мирового кажется карликом. Однако внимание со стороны бизнеса и государства в ближайшие годы предоставит ему широкие возможности для опережающего развития. 0 Обсудить 28 просмотров По данным S...
04.11.2021	PROCEPT BioRobotics Corp. Reports Third Quarter 2021 Financial Results and Provides 2021 Revenue Guidance	REDWOOD CITY, Calif., Nov. 04, 2021 (GLOBE NEWSWIRE) -- PROCEPT® BioRobotics Corporation (Nasdaq: PRCT), a surgical robotics company focused on advancing patient care by developing transformative solutions in urology, today reported financi...
30.06.2021	Procept Biorobotics reels in $85M to make a splash with water-based robotic system for prostate surgery	With an estimated 40 million men in the U.S. living with benign prostatic hyperplasia, or BPH, Procept Biorobotics has developed a treatment device that certainly holds water. Literally: The AquaBeam Robotic System uses a heat-free jet of w...
30.06.2021	Procept Biorobotics reels in $85M to make a splash with water-based robotic system for prostate surgery Age-Appropriate Formulation Development for Pediatric Trials-Challenges and Considerations	With an estimated 40 million men in the U.S. living with benign prostatic hyperplasia, or BPH, Procept Biorobotics has developed a treatment device that certainly holds water. RELATED: Olympus buys partner Medi-Tate and its minimally invasi...
30.06.2021	PROCEPT® BioRobotics Announces $85M Financing Led by Fidelity Management & Research Company LLC
16.11.2020	PROCEPT BioRobotics Announces Full Medicare Coverage for Aquablation Therapy for Enlarged Prostate
06.02.2020	PROCEPT BioRobotics hires Avedro's Reza Zadno as new president and CEO	The company uses robots to assistant in prostate surgery Surgical robotics are on the rise, with a global market that's expected to grow from $56 million in 2017 to $98 million by 2024, nearly doubling in that time. As such, there are a bun...
26.02.2018	Term Sheet — Monday, February 26	A TOKENIZED WORLD Good morning, Term Sheet readers. Paid Content Securing the enterprise without boundaries From ExtraHop • The acquisition instantly makes Circle a rising threat to Coinbase’s GDAX, which is currently the biggest cryptocurr...
22.02.2018	Term Sheet — Thursday, February 22	THE KING OF RIDE-HAILING Good morning, Term Sheet readers. Paid Content Securing the enterprise without boundaries From ExtraHop Recently, reports emerged that Uber has decided to sell its Southeast Asia business to ride-hailing startup, Gr...
21.02.2018	Procept BioRobotics Raises $118M in Financing	Procept BioRobotics, a Redwood Shores, Calif.-based surgical robotics company, raised $118m in an equity financing. The round was led by new investor Viking Global Investors LP, with participation from new investor Perceptive Advisors and e...
09.02.2018	Stanford spin-out Zenflow raises $31M to join the megamarket for enlarged prostate	In a phone interview, Damiano said the startup “threw out a broad net” for funding and between 2015 and 2017, it hauled in $5.2 million in seed funding, mostly from angel investors. Along the way, it was supported by the StartX accelerator ...
07.07.2015	PROCEPT BioRobotics Raises $42M in Funding	PROCEPT BioRobotics, a Redwood Shores, Calif.-based medical device company, raised $42m in funding. The round was led by Novo A/S with participation from CPMG and others. The company intends to use the funds for a limited commercial launch ...
07.07.2015	Procept BioRobotics Lands $42M	REDWOOD SHORES, CA, PROCEPT BioRobotics, a privately held medical device company based in Silicon Valley, announced today the closing of $42 million in a venture round of equity financing led by Novo A/S. >> Click here for more fun...
-	Stanford spin-out Zenflow raises $31M to join the megamarket for enlarged prostate	A San Francisco, California-based medical device startup, Zenflow, has announced a $31.4 million Series A financing round to further its minimally-invasive approach to treating benign prostatic hyperplasia (BPH) or enlarged prostate. The co...

PROCEPT BIOROBOTICS

Investors 1

Funding Rounds 3

Mentions in press and media 18

Reviews 0